Main phenotypes and histological types of breast cancer in young women attended at a reference hospital in women’s health in the city of São Paulo

Author:

Rodrigues de Souza Guilherme Moreno12ORCID,Carvalho Anderson Fernandes1,Santiago Simone Ferreira2,M R Pinho Maria Aparecida2,Ramadan Débora Ribeiro2,Tufik Sérgio2,Feres Marcia C2

Affiliation:

1. Escola Ciências da Saúde da Universidade Anhembi Morumbi, SP, Brazil

2. Associação Fundo de Incentivo à Pesquisa, SP, Brazil

Abstract

It is estimated that there were 198,840 new cases of breast cancer (BC) in Brazil between 2020 and 2022. Young women who are affected by invasive BC with a triple-negative phenotype generally present more aggressive tumors that are intrinsically resistant to targeted therapies. This study evaluated the phenotypic and histological profile of BC in women up to the age of 40 years. Between 2015 and 2017, we identified 255 women with positive biopsy for carcinoma and with immunohistochemical panel, 51.76% who had a profile for luminal B (n = 132); 22.74% for triple-negative (n = 58). Of the samples, 65.88% presented histology as invasive ductal carcinoma – nonspecial type (n = 168). The results are in accordance with the literature regarding the high prevalence of triple-negative BC in young women and histological type invasive ductal carcinoma – nonspecial type.

Publisher

Future Medicine Ltd

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference29 articles.

1. Instituto Nacional do Câncer José de Alencar Gomes da Silva (BR). Estimativa 2020: incidência de câncer no Brasil. INCA, Rio de Janeiro, Brazil, 120 (2019). www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf

2. Instituto Nacional do Câncer José de Alencar Gomes da Silva (BR). Atlas on-line de mortalidade. INCA, Rio de Janeiro, Brazil (2014). www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//informativo-vigilancia-do-cancer-n5-edicao-especial-2014.pdf.pdf

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

4. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

5. Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3